No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
about
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhageManagement of delayed cerebral ischemia after subarachnoid hemorrhageLow-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.Treatment of intracranial vasospasm following subarachnoid hemorrhage.Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage.Neuroprotection in subarachnoid hemorrhageHypothermia as a neuroprotective strategy in subarachnoid hemorrhage: a pathophysiological review focusing on the acute phase.Racial differences in cerebral vasospasm: a systematic review of the literature.A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controls.Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions.Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.Medical management of patients with aneurysmal subarachnoid haemorrhage.Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke.Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage.The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage.Novel Treatments in Neuroprotection for Aneurysmal Subarachnoid Hemorrhage.Heparin and Heparin-Derivatives in Post-Subarachnoid Hemorrhage Brain Injury: A Multimodal Therapy for a Multimodal Disease.Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.Predictors of work status and quality of life 9-13 years after aneurysmal subarachnoid hemorrahage.Relationship of local infarctions to cognitive and psychosocial impairments after aneurysmal subarachnoid hemorrhage.Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity.High-Dose Nadroparin Following Endovascular Aneurysm Treatment Benefits Outcome After Aneurysmal Subarachnoid Hemorrhage.Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage.Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.Aneurysmal Subarachnoid Hemorrhage.Heparin: The Silver Bullet of Aneurysmal Subarachnoid Hemorrhage?Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage.
P2860
Q27003355-75848A02-1C19-4B9B-86DB-A2DBF6266208Q28076405-3FC85057-5D0E-47F7-964E-0837F6FF2680Q33410310-EEF63483-76D3-4187-8F10-AE0B71A63BB2Q33658415-1219A523-CAD3-45D2-90CD-D60303230E25Q34448852-C60B68A8-9C55-4D89-BBA7-E0ABE94E84BCQ35108572-A870D189-F425-4B2B-9555-3546A2397BA0Q35574105-9186BB7E-1D7E-49CB-A2A6-C3EB1AA9D34AQ36034824-F41B9EF8-5B0C-4B31-A32B-25B71E470E5FQ36104033-AA5F5E12-CF60-4C76-B57D-B55F471C2A3FQ36389156-801002F4-E556-4F56-821C-11DABA39B32CQ36632180-EC15BA03-79DA-4148-812B-FBCA29A6BF04Q36831190-4D8B4BF8-2E59-4901-8263-FE59A1C8CFCCQ37217250-3AA09647-C753-416B-A34E-0E280DECCF92Q37244421-A8A9CC0C-F1FD-436B-8098-88AC2076F8FAQ37898337-2A0572FB-2CB1-4FC5-B9D4-A17F487C9CDEQ37973007-24E4401E-9DD7-4ABE-9D45-DA1BD1F1632EQ38213375-467A9C71-2796-4CDC-9471-FCD24B2BA566Q38871467-03B426B4-E9D2-4F5D-9882-9E43803BD2FAQ39281099-CE48CFB3-ACA7-40AE-B84A-F3AB464E7BF6Q40980336-494B5124-E15F-4513-957A-46AC4413B410Q43948884-8BB9E53C-3ABF-4D02-9A1F-2D56C0807240Q45085987-2F8834FF-392A-4E56-B0AB-AC5076E0829FQ45936233-4680E76A-4F3B-4327-B3AE-39A9A694116BQ46574831-DD6DF7AF-1E79-423E-8411-14715EB51FE2Q47926401-6276FCC5-403D-4A91-89AD-225A4B31A955Q48876329-1225EE0D-5190-47C5-BD4C-23363AF1765DQ53079755-A3C1CC19-41DA-4438-A292-04A76F9D598CQ53083421-D25896B0-9298-465C-83F8-F763F1A020E6Q55246147-A3744E87-F108-4326-A13D-55613E9D1830Q55362801-6E68C38A-C0D1-4C79-9D64-ACBD1504D101
P2860
No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@en
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@nl
type
label
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@en
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@nl
prefLabel
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@en
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@nl
P2093
P1476
No effect of enoxaparin on out ...... ebo-controlled clinical trial.
@en
P2093
Jari Siironen
Joona Varis
Juha Hernesniemi
Kristiina Poussa
Matti Porras
Riitta Lassila
Seppo Juvela
Sorella Ilveskero
P304
P356
10.3171/JNS.2003.99.6.0953
P407
P577
2003-12-01T00:00:00Z